Your browser doesn't support javascript.
loading
Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysis.
Somasegar, Sahana; Reddy, Ravali A; Chow, Stephanie; Dorigo, Oliver; Renz, Malte; Karam, Amer.
Afiliación
  • Somasegar S; Stanford University School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Palo Alto, CA, United States of America. Electronic address: ssomaseg@stanford.edu.
  • Reddy RA; Stanford University School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Palo Alto, CA, United States of America.
  • Chow S; Stanford University School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Palo Alto, CA, United States of America.
  • Dorigo O; Stanford University School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Palo Alto, CA, United States of America.
  • Renz M; Stanford University School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Palo Alto, CA, United States of America.
  • Karam A; Stanford University School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Palo Alto, CA, United States of America.
Gynecol Oncol ; 184: 190-197, 2024 05.
Article en En | MEDLINE | ID: mdl-38330833
ABSTRACT

OBJECTIVE:

To characterize trends in ovarian, fallopian tube, and primary peritoneal cancer incidence and incidence-based mortality based on histology and site of origin.

METHODS:

We obtained age-adjusted incidence and incidence-based mortality for patients with ovarian, fallopian tube, and primary peritoneal cancer from 2000 to 2019 from the US SEER 17 database. Joinpoint 4.9.1.0 was used to characterize log-linear time trends.

RESULTS:

The incidence and incidence-based mortality of all cancers trended down during the study period. The incidence of epithelial cancers decreased from 2004 to 2019 (AAPC -1.2%, p < 0.001), including that of high-grade (2006-2019 APC -1.2%, p < 0.05) and low-grade (2003-2019 APC -2.4%, p < 0.05) epithelial cancers. There was no change in incidence or incidence-based mortality for ovarian stromal and germ cell cancers.

CONCLUSION:

There has been a decrease in the incidence and incidence-based mortality of ovarian, fallopian tube, and primary peritoneal cancer, primarily due to reductions in advanced stage epithelial cancers originating in the ovary, fallopian tube, or peritoneum.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Programa de VERF / Neoplasias de las Trompas Uterinas Tipo de estudio: Incidence_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Programa de VERF / Neoplasias de las Trompas Uterinas Tipo de estudio: Incidence_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2024 Tipo del documento: Article